Chemotherapy and immunotherapy: mapping the road ahead AM Cook, WJ Lesterhuis, AK Nowak, RA Lake Current opinion in immunology 39, 23-29, 2016 | 136 | 2016 |
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in AK Nowak, WJ Lesterhuis, PS Kok, C Brown, BGM Hughes, DJ Karikios, ... The Lancet Oncology 21 (9), 1213-1223, 2020 | 135 | 2020 |
Identification of a bipotent epithelial progenitor population in the adult thymus S Ulyanchenko, KE O’Neill, T Medley, AM Farley, HJ Vaidya, AM Cook, ... Cell reports 14 (12), 2819-2832, 2016 | 112 | 2016 |
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma AK Nowak, AM Cook, AM McDonnell, MJ Millward, J Creaney, RJ Francis, ... Annals of Oncology 26 (12), 2483-2490, 2015 | 95 | 2015 |
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies AM Cook, AM McDonnell, RA Lake, AK Nowak Oncoimmunology 5 (3), e1066062, 2016 | 73 | 2016 |
Enhancing the efficacy of immunotherapy using radiotherapy S Keam, S Gill, MA Ebert, AK Nowak, AM Cook Clinical & Translational Immunology 9 (9), e1169, 2020 | 49 | 2020 |
Antiangiogeneic strategies in mesothelioma AK Nowak, S Brosseau, A Cook, G Zalcman Frontiers in oncology 10, 126, 2020 | 38 | 2020 |
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment WJ Aston, DE Hope, AM Cook, L Boon, I Dick, AK Nowak, RA Lake, ... Oncoimmunology 8 (11), e1641390, 2019 | 28 | 2019 |
Immune checkpoint inhibition for the treatment of mesothelioma AK Nowak, A McDonnell, A Cook Expert Opinion on Biological Therapy 19 (7), 697-706, 2019 | 23 | 2019 |
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors SJ Dart, AM Cook, MJ Millward, AM McDonnell, WL Chin, MU Hakeem, ... Scientific Reports 11 (1), 15312, 2021 | 17 | 2021 |
Older patients are immunocompromised by cytokine depletion and loss of innate immune function after HIP fracture surgery AG Sutherland, A Cook, C Miller, L Duncan, R Yuecel, SD Heys, ... Geriatric orthopaedic surgery & rehabilitation 6 (4), 295-302, 2015 | 16 | 2015 |
In vivo noninvasive preclinical tumor hypoxia imaging methods: a review RA D’Alonzo, S Gill, P Rowshanfarzad, S Keam, KM MacKinnon, ... International Journal of Radiation Biology 97 (5), 593-631, 2021 | 12 | 2021 |
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors J Chee, MW Watson, A Chopra, B Nguyen, AM Cook, J Creaney, ... BMC research notes 11, 1-6, 2018 | 10 | 2018 |
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell … AM McDonnell, A Cook, BWS Robinson, RA Lake, AK Nowak BMC cancer 17, 1-15, 2017 | 9 | 2017 |
Immune checkpoint inhibitor therapy for malignant pleural mesothelioma AK Nowak, WL Chin, S Keam, A Cook Lung Cancer 162, 162-168, 2021 | 7 | 2021 |
Proliferation and lineage potential in fetal thymic epithelial progenitor cells AM Cook The University of Edinburgh, 2010 | 5 | 2010 |
The future of mesothelioma research: basic science research VS Fear, AM Cook, SA Fisher Caring for Patients with Mesothelioma: Principles and Guidelines, 203-227, 2019 | 3 | 2019 |
Effects of Photon Radiation on DNA Damage, Cell Proliferation, Cell Survival, and Apoptosis of Murine and Human Mesothelioma Cell Lines S Keam, KM MacKinnon, RA D'Alonzo, S Gill, MA Ebert, AK Nowak, ... Advances in Radiation Oncology 7 (6), 101013, 2022 | 2 | 2022 |
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers AM Cook, A McDonnell, MJ Millward, J Creaney, A Hasani, M McMullen, ... Expert Review of Anticancer Therapy 21 (5), 465-474, 2021 | 1 | 2021 |
Immune marker expression of irradiated mesothelioma cell lines F Chang, S Keam, TS Hoang, J Creaney, S Gill, AK Nowak, M Ebert, ... Frontiers in Oncology 12, 1020493, 2022 | | 2022 |